This company has been marked as potentially delisted and may not be actively trading. SpringWorks Therapeutics (SWTX) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock SpringWorks Therapeutics (NASDAQ:SWTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.83%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$25.24M Get SWTX Insider Trade Alerts Want to know when executives and insiders are buying or selling SpringWorks Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SWTX Insider Buying and Selling by Quarter SpringWorks Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/2/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$46.99$1,001 - $15,0007/1/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Sell$46.99$15,001 - $50,0003/3/2025Badreddin EdrisCOOSell20,000$54.23$1,084,600.00 3/3/2025Saqib IslamCEOSell49,000$54.24$2,657,760.00 2/20/2025Bhavesh AsharInsiderSell1,016$61.19$62,169.04 2/20/2025Daniel LynchDirectorSell47,600$60.22$2,866,472.00 2/20/2025Saqib IslamCEOSell29,328$60.30$1,768,478.40 2/14/2025Daniel LynchDirectorSell400$60.00$24,000.00 2/14/2025Saqib IslamCEOSell10,672$59.92$639,466.24 2/10/2025Badreddin EdrisCOOSell30,000$53.13$1,593,900.00 2/10/2025Daniel LynchDirectorSell175,000$54.46$9,530,500.00 2/10/2025Daniel PichlInsiderSell29,750$54.36$1,617,210.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/10/2025Saqib IslamCEOSell48,000$53.30$2,558,400.00 1/29/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Buy$36.52$1,001 - $15,00012/3/2024Badreddin EdrisCOOSell20,000$41.97$839,400.00 (Data available from 1/1/2013 forward) SWTX Insider Trading Activity - Frequently Asked Questions Who is on SpringWorks Therapeutics' Insider Roster? The list of insiders at SpringWorks Therapeutics includes Badreddin Edris, Bhavesh Ashar, Daniel Lynch, Daniel Pichl, Julie Hambleton, and Saqib Islam. Learn more on insiders at SWTX. What percentage of SpringWorks Therapeutics stock is owned by insiders? 7.83% of SpringWorks Therapeutics stock is owned by insiders. Learn more on SWTX's insider holdings. Which SpringWorks Therapeutics insiders have been selling company stock? The following insiders have sold SWTX shares in the last 24 months: Badreddin Edris ($3,517,900.00), Bhavesh Ashar ($62,169.04), Daniel Lynch ($12,420,972.00), Daniel Pichl ($2,368,710.00), and Saqib Islam ($7,624,104.64). How much insider selling is happening at SpringWorks Therapeutics? Insiders have sold a total of 475,766 SpringWorks Therapeutics shares in the last 24 months for a total of $25,993,855.68 sold. Which members of congress are trading SpringWorks Therapeutics? Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of SpringWorks Therapeutics in the last year totaling $8,000. Josh Gottheimer (D-NJ) and Gilbert Ray Cisneros, Jr. (D-CA) have sold shares totaling $40,500. SpringWorks Therapeutics Key ExecutivesMr. Saqib Islam J.D. (Age 54)CEO & Director Compensation: $1.49MMr. Francis I. Perier Jr. (Age 64)M.B.A., Chief Financial Officer Compensation: $768.24kDr. Badreddin Edris Ph.D. (Age 37)Chief Operating Officer Compensation: $1.02MDr. James Cassidy M.D. (Age 64)Ph.D., Chief Medical Officer Compensation: $904.25kMr. Michael P. Nofi (Age 53)Chief Accounting Officer Mr. Tai-An Lin Ph.D.Chief Scientific OfficerMs. Kim DiamondVice President of Communications & Investor RelationsMr. Herschel S. Weinstein J.D. (Age 67)General Counsel & Secretary Compensation: $568.64kMr. Daniel J. Pichl (Age 40)Chief People Officer Compensation: $428.51kMr. Bhavesh Ashar M.B.A. (Age 58)Chief Commercial Officer Compensation: $729.62k More Insider Trading Tools from MarketBeat Related Companies VTRS Insider Ownership ROIV Insider Ownership BBIO Insider Ownership MRNA Insider Ownership ELAN Insider Ownership VRNA Insider Ownership RVMD Insider Ownership RNA Insider Ownership CYTK Insider Ownership MRUS Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Healthcare Companies Insiders Are Buying Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry This page (NASDAQ:SWTX) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
